These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26627264)

  • 1. Focal hepatic glycogenosis associated with metastatic insulinoma presenting as mass lesions.
    Vyas M; Zhang X; Morrow JS; Jain D; Salem RR; West AB
    Pathol Res Pract; 2016 Jan; 212(1):59-62. PubMed ID: 26627264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal hepatic steatosis surrounding a metastatic insulinoma.
    Takeshita A; Yamamoto K; Fujita A; Hanafusa T; Yasuda E; Shibayama Y
    Pathol Int; 2008 Jan; 58(1):59-63. PubMed ID: 18067643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.
    Bannasch P
    World J Gastroenterol; 2012 Dec; 18(46):6701-8. PubMed ID: 23239906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes.
    Chatila R; West AB
    Medicine (Baltimore); 1996 Nov; 75(6):327-33. PubMed ID: 8982149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic insulinoma and glucagonoma from the pancreas responsible for specific peritumoral patterns of hepatic steatosis secondary to local effects of insulin and glucagon on hepatocytes.
    Fregeville A; Couvelard A; Paradis V; Vilgrain V; Warshauer DM
    Gastroenterology; 2005 Oct; 129(4):1150,1365. PubMed ID: 16247938
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis.
    Allende DS; Gawrieh S; Cummings OW; Belt P; Wilson L; Van Natta M; Behling CA; Carpenter D; Gill RM; Kleiner DE; Yeh MM; Chalasani N; Guy CD;
    Liver Int; 2021 May; 41(5):996-1011. PubMed ID: 33354866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin edema in hepatic glycogenosis].
    Mahévas T; Gobert D; Gatfossé M; Mekinian A; Fain O
    Rev Med Interne; 2017 Mar; 38(3):201-203. PubMed ID: 27745935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Hepatic Glycogenosis in a Patient With Uncontrolled Diabetes Mellitus Type 1.
    Glushko T; Kushchayev SV; Trifanov D; Salei A; Morales D; Berry G; Mackey J; Teytelboym OM
    J Comput Assist Tomogr; 2018; 42(2):230-235. PubMed ID: 28937487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic glycogenosis: a diagnostic challenge.
    Horta D; Escoda MR; Melcarne L
    Rev Esp Enferm Dig; 2017 Aug; 109(8):599-600. PubMed ID: 28625068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma associated with liver lesions: value of MR imaging.
    Vandevenne JE; Deckers F; Mana F; Küçükaycan M; d'Archambeau O; De Schepper AM
    Am J Gastroenterol; 1998 Sep; 93(9):1559-62. PubMed ID: 9732946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant insulinoma causing liver metastasis 8 years after the initial surgery: report of a case.
    Sata N; Kimura W; Kanazawa T; Muto T
    Surg Today; 1995; 25(7):640-2. PubMed ID: 7549277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malignant hypoglycaemia].
    Rigger J; Kleger GR; Semela D; Doenecke C; Rodriguez R; Meyenberger C; Köberle D; Sawatzki M
    Praxis (Bern 1994); 2014 Mar; 103(7):399-403. PubMed ID: 24686761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.
    Nehrbass D; Klimek F; Bannasch P
    Am J Pathol; 1998 Feb; 152(2):341-5. PubMed ID: 9466558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant insulinoma: a report of 3 cases and review of the literature.
    Callacondo D; Arenas JL; Ganoza AJ; Rojas-Camayo J; Quesada-Olarte J; Robledo H
    Pancreas; 2013 Nov; 42(8):1323-32. PubMed ID: 24152958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic glycogenosis; enzyme study].
    Gilly R; Reynier M; Ricci R; Vernon L; Chamfeuil R; Marty J
    Mars Med; 1970 Jun; 107(6):451-6. PubMed ID: 5269978
    [No Abstract]   [Full Text] [Related]  

  • 16. Metastatic insulinoma: case report and review of the literature.
    Tran TH; Pathak RD; Basa AL
    South Med J; 2004 Feb; 97(2):199-201. PubMed ID: 14982275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular glycogenosis and hepatocarcinogenesis.
    Bannasch P; Mayer D; Hacker HJ
    Biochim Biophys Acta; 1980 May; 605(2):217-45. PubMed ID: 6994813
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.
    Thompson SM; Vella A; Thompson GB; Rumilla KM; Service FJ; Grant CS; Andrews JC
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4189-97. PubMed ID: 26312578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal hepatic glycogenosis.
    Bannasch P; Jahn U; Hacker H; Su Q; Hoffmann W; Pichlmayr R; Otto G
    Int J Oncol; 1997 Feb; 10(2):261-8. PubMed ID: 21533371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver phosphorylase deficiency in glycogenosis type VI: documentation by biochemical analysis of hepatic biopsy specimens.
    Hug G; Chuck G; Walling L; Schubert WK
    J Lab Clin Med; 1974 Jul; 84(1):26-35. PubMed ID: 4525529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.